Latest News
NEC joins €6.5m European project using AI for pandemic vaccine design
November 6, 2026EU, Immunology, Infections and infestations, Pharmacy, Vaccine, collaboration, pandemic
NEC OncoImmunity, a subsidiary of NEC Corporation, is leading the AI-powered antigen prediction and vaccine design work in a four-year …
Survey highlights mental health burden among rare disease patients and families
November 5, 2026Psychiatry, Rare Diseases, neurology, rare disease, survey
Seven in 10 people affected by rare diseases, including patients and family members, report poor mental health, according to a …
Stryker invests US$400m in CMR Surgical and secures option to acquire business
November 3, 2026Devices, acquisitions, healthcare market, investment, medical technology
US medical technology company Stryker is investing approximately US$400m (£300m) in UK surgical robotics developer CMR Surgical, alongside securing an …
Tezspire improves symptoms and tissue inflammation in phase 3 EoE trial
November 2, 2026Gastrointestinal tract, clinical trial, drug delivery, gastrointestinal, inflammation
AstraZeneca and Amgen’s Tezspire (tezepelumab) has demonstrated significant improvements in tissue inflammation and swallowing symptoms in patients with eosinophilic oesophagitis …
Capital Dynamics invests €14m in Italian community healthcare platform CareHub
October 30, 2026Corporate, Diagnostics, Hospital Management, community healthcare, nline platforms, private equity
Private asset manager Capital Dynamics has invested €14m in Celsus Holding, the holding company through which private equity fund Silver …
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026Cardiology, Devices, Oncology, cardiology, medical devices
Medtronic has received CE Mark approval for its Vitalis portfolio of five pacemakers, including a device designed for patients who …
East London pharmacies pilot cholesterol-lowering injections to cut waiting times
October 29, 2026Cardiology, Chronic Diseases, Hospital Management, NICE, cardiology, cholesterol, community healthcare, pharmacies
A pilot scheme in east London is offering cholesterol-lowering injections at community pharmacies to help patients access treatment sooner and …
Charity commits £800,000 to AI research into late breast cancer recurrence
October 28, 2026AI, Immunology, Oncology, breast cancer, cytology, oncology, research and development
Breast Cancer Now is investing £800,000 in two research projects using artificial intelligence to investigate why oestrogen receptor-positive (ER-positive) breast …
AstraZeneca’s Trixeo approved in EU for asthma in patients aged 12 and over
October 27, 2026Asthma & COPD, COPD, EMA, EU, Pharmacy, asthma
AstraZeneca’s Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate dihydrate) has been approved by the European Commission as a maintenance treatment for asthma in …
Sobi’s olezarsen recommended for EU approval in severe hypertriglyceridaemia
October 27, 2026Chronic Diseases, EMA, Pain, Pharmacy, drug development, regulatory
Sobi’s olezarsen (TRYNGOLZA) has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use …
Hot-tub therapy tested as potential treatment for peripheral artery disease
October 26, 2026Cardiology, PAD, Pain, cardiology
Researchers at Manchester Metropolitan University are investigating whether regular hot-water immersion can improve mobility and relieve pain in people with …
Most advanced breast cancer patients treated in community settings, Phesi study finds
October 26, 2026Oncology, breast cancer, clinical trials, community healthcare, oncology
Most patients with advanced hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer are treated in community settings rather than academic centres, potentially …
Orforglipron shows weight and glucose advantages over oral semaglutide in indirect comparison
October 23, 2026Diabetes, Obesity, Peptide therapies, clinical trials, diabetes, weight reduction
Pharmaceutical firm Lilly’s orforglipron was associated with greater reductions in body weight and blood glucose than oral semaglutide in adults …
Bramacare opens supported-living facility for eating disorder recovery
October 23, 2026Psychiatry, eating disorders, supported living
Bramacare has opened a new facility in Ipswich offering supported living for adults recovering from complex eating disorders, providing a …
Aiforia deal to expand access to pathology AI
October 22, 2026AI, Corporate, Devices, Hospital Management, commercial agreements, digital pathology
Aiforia has signed a commercial agreement with PathAI to make its artificial intelligence (AI) solutions for digital pathology available to …
Latest content
The evidence bar impacting UK medical cannabis access
Addressing the rheumatic disease diagnostic gap in primary care
